Clinical Trials Directory

Trials / Completed

CompletedNCT05030610

Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic Adults

Treating Depression in Autistic Adults: A Feasibility Trial of an Adapted Behavioral Activation Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study aims to adapt and evaluate the feasibility of the BeatIt behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with autistic individuals, with and without intellectual disabilities.

Detailed description

The study has two specific aims: 1. Adapt BeatIt materials for use with autistic adults with and without Intellectual Disability (ID). Focus groups engaging key stakeholders will inform the adaptation of BeatIt for autistic adults (i.e., BeatIt-ASD). A stakeholder advisory team will provide input through the duration of the study. 2. Evaluate the feasibility, acceptability, and preliminary efficacy of BeatIt-ASD for autistic adults. This includes examining if the data demonstrate the feasibility and acceptability of the BeatIt-ASD program for autistic adults and provide preliminary evidence for behavioral change (i.e., increased engagement in meaningful activities and reduced depressive symptoms). Data will demonstrate the feasibility and acceptability of the adapted BeatIt intervention for autistic adults and provide preliminary evidence for reduction of depression symptoms via regulation of routines and achievement of meaningful goals.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBeatIt-ASDBeatIt-ASD, designed to be implemented with autistic individuals, is an adaptation of BeatIt. The intervention aims to improve mood and decrease depressive symptoms through an increase in meaningful engagement in recreational, domestic, and social/leisure activities.

Timeline

Start date
2021-08-25
Primary completion
2022-12-07
Completion
2022-12-07
First posted
2021-09-01
Last updated
2023-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05030610. Inclusion in this directory is not an endorsement.